FNY Managed Accounts’s Medifast MED Stock Holding History
Bought
Maintained
Sold
Other funds holding MED
MWNA
FNY Managed Accounts's MED Position: Q1 2018 in Review
FNY Managed Accounts reduced its Medifast (MED) stake by 33% in Q1 2018, selling an estimated $1.2K and leaving 32 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #404.
FNY Managed Accounts first reported a position in MED in Q3 2017 and has held it in 3 quarters since. The position peaked at $24K in Q3 2017. 225 funds tracked by Wall St. Rank hold MED as of Q1 2018.
- FNY Managed Accounts held 32 shares of Medifast worth $2K as of Q1 2018.
- FNY Managed Accounts sold 16 Medifast shares in Q1 2018, an estimated $1.2K.
- Medifast made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #404 holding.
- FNY Managed Accounts first reported a position in Medifast in Q3 2017 and has held it in 3 quarters since.
- FNY Managed Accounts's Medifast position peaked at $24K in Q3 2017.
- 225 funds tracked by Wall St. Rank held Medifast as of Q1 2018.
Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.